$66.26 -0.82 (%) Anacor Pharmaceuticals Inc - NASDAQ

Apr. 28, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. Mid-Afternoon Market Update: Crude Oil Climbs 6%; Sprint Shares Gain Following Strong Q3 Earnings

    Benzinga | Jan. 26, 2016 | 14:40PM EST
  2. Mid-Day Market Update: Dow Surges Over 250 Points; Firstmerit Shares Rise On Acquisition News

    Benzinga | Jan. 26, 2016 | 12:02PM EST
  3. The Best-Performing Non-S&P Stocks of 2015

    GuruFocus | Dec. 30, 2015 | 16:01PM EST
  4. Top-Performing Non-S&P 500 Stocks of the Year

    GuruFocus | Dec. 30, 2015 | 16:01PM EST
  5. Top Stocks 2015: Biotechs, Wayfair, Netflix, Amazon

    IBD | Dec. 30, 2015 | 08:02AM EST
  6. Cowen: In Biotech Earnings We Trust

    Benzinga | Oct. 19, 2015 | 10:02AM EST
  7. Royce Funds Comments on Anacor Pharmaceuticals

    GuruFocus | Oct. 12, 2015 | 12:26PM EST
  8. Anacor Pharma Reports Presentations of Crisaborole Topical Ointment, 2% Phase 3 Pivotal Data at Two Upcoming Conferences

    Benzinga | Sep. 29, 2015 | 08:31AM EST
  9. Here Are a Few Stocks With Fat Profit Margins

    GuruFocus | Sep. 3, 2015 | 13:54PM EST
  10. Panic-Proofing the Small Investor

    GuruFocus | Aug. 26, 2015 | 13:16PM EST
  11. Benzinga's Top Upgrades

    Benzinga | Jul. 21, 2015 | 09:28AM EST
  12. Goldman Sachs Upgrades Anacor Pharma To Buy On 'De-Risked' Story

    Benzinga | Jul. 21, 2015 | 07:15AM EST
  13. Preliminary Results of Two Phase 3 Pivotal Studies - Report on Anacor Pharmaceuticals, Inc.

    Benzinga | Jul. 16, 2015 | 09:10AM EST
  14. Dermatitis Drugs Clear Rash

    IBD | Jul. 13, 2015 | 18:54PM EST
  15. Biotechs up on rash drugs

    IBD | Jul. 13, 2015 | 18:54PM EST
  16. Anacor Shares Surge To All-Time Highs After Phase 3 Trials Of Eczema Drug

    Benzinga | Jul. 13, 2015 | 15:29PM EST
  17. Wedbush On Anacor Pharma: Crisaborole Delivers, Reiterate Outperform

    Benzinga | Jul. 13, 2015 | 14:33PM EST
  18. Monday's Mid-Day Movers: Greece Reaches Deal, Dow Up Triple Digits

    Benzinga | Jul. 13, 2015 | 12:58PM EST
  19. Anacor, Regeneron Up On Promising Rash Treatments

    IBD | Jul. 13, 2015 | 12:21PM EST
  20. Mid-Morning Market Update: Markets Open Higher; BorgWarner To Acquire Remy International For $29.50/Share

    Benzinga | Jul. 13, 2015 | 10:40AM EST
  21. Benzinga's Volume Movers

    Benzinga | Jul. 13, 2015 | 10:16AM EST
  22. Morning Market Gainers

    Benzinga | Jul. 13, 2015 | 09:39AM EST
  23. Stock Futures Rise On Greek Deal; Anacor, Edwards Lifesciences Rising

    IBD | Jul. 13, 2015 | 09:13AM EST
  24. Benzinga's Top #PreMarket Gainers

    Benzinga | Jul. 13, 2015 | 08:10AM EST
  25. Who's The Next Big Pharma Acquisition?

    Benzinga | May. 29, 2015 | 11:20AM EST
  26. Cohen Has Busy Third Quarter

    GuruFocus | Nov. 19, 2014 | 09:43AM EST
  27. Stocks Hitting 52-Week Highs

    Benzinga | Oct. 20, 2014 | 10:08AM EST
  28. Anacor Pharmaceuticals, Inc. Announces Proposed Offering of $70M Of Convertible Senior Notes Due 2021

    Benzinga | Oct. 8, 2014 | 16:01PM EST
  29. Paulson Bets Again On Mallinckrodt

    GuruFocus | Aug. 7, 2014 | 11:02AM EST
  30. Benzinga's Volume Movers

    Benzinga | Jul. 21, 2014 | 10:31AM EST
  31. Anacor Pharmaceuticals And Sandoz Enter Into An Agreement For The Commercialization Of KERYDIN In The United States

    Benzinga | Jul. 21, 2014 | 07:03AM EST
  32. 5-Star Biotech Stock Watch: Anacor Pharmaceuticals

    Benzinga | Jul. 2, 2014 | 11:09AM EST
  33. Mid-Afternoon Market Update: Markets Go Red as Anadarko Rallies on Settlement with US

    Benzinga | Apr. 3, 2014 | 15:45PM EST
  34. Mid-Day Market Update: US Stocks Fall; Google Shares Rise After Stock Split

    Benzinga | Apr. 3, 2014 | 12:41PM EST
  35. US Stock Futures Up Ahead Of Chicago PMI

    Benzinga | Mar. 31, 2014 | 07:31AM EST
  36. Earnings Scheduled For March 13, 2014

    Benzinga | Mar. 13, 2014 | 04:51AM EST
  37. Anacor Pharmaceuticals Announces Successful Completion of End-of-Phase 2 Meeting With FDA for the Treatment of Mild-to-Moderate Atopic Dermatitis With AN2728

    Benzinga | Feb. 27, 2014 | 07:32AM EST
  38. Valeant Pharmaceuticals

    IBD | Oct. 28, 2013 | 18:52PM EST
  39. Anacor Pharmaceuticals Awarded $13.5M in Research Agreement with Defense Threat Reduction Agency

    Benzinga | Oct. 21, 2013 | 09:14AM EST
  40. Benzinga's Top Pre-Market Gainers

    Benzinga | Oct. 18, 2013 | 08:07AM EST
  41. Anacor Pharmaceuticals Announces Award of $100M in Arbitration with Valeant

    Benzinga | Oct. 17, 2013 | 23:29PM EST
  42. These Three Speculative Companies Are Loved By Insiders and Institutions

    Benzinga | Aug. 22, 2013 | 11:55AM EST
  43. Weekly CFO Buys Highlight

    GuruFocus | Aug. 19, 2013 | 13:32PM EST
  44. 3 Great Dividend Stocks at All-Time Highs

    GuruFocus | Aug. 19, 2013 | 13:31PM EST
  45. Stocks Hitting 52-Week Highs

    Benzinga | Aug. 14, 2013 | 10:40AM EST
  46. Stocks Hitting 52-Week Lows

    Benzinga | Feb. 11, 2013 | 03:32AM EST
  47. Stocks Hitting 52-Week Lows

    Benzinga | Jan. 29, 2013 | 03:30AM EST
  48. A Peek Into The Market Before The Trading Starts

    Benzinga | Jan. 29, 2013 | 00:22AM EST
  49. Anacor Pharmaceuticals Announces Positive Phase 3 Trial Results for Tavaborole for Onychomycosis

    Benzinga | Jan. 29, 2013 | 00:05AM EST
  50. Anacor Pharmaceuticals Announces Positive Results From Phase 2 Trial of AN2728

    Benzinga | Dec. 10, 2012 | 09:01AM EST
Trading Center